Guiwen Guan

694 total citations
28 papers, 453 citations indexed

About

Guiwen Guan is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Guiwen Guan has authored 28 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Molecular Biology and 11 papers in Hepatology. Recurrent topics in Guiwen Guan's work include Hepatitis B Virus Studies (13 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (8 papers). Guiwen Guan is often cited by papers focused on Hepatitis B Virus Studies (13 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (8 papers). Guiwen Guan collaborates with scholars based in China, United States and Slovakia. Guiwen Guan's co-authors include Xiangmei Chen, Fengmin Lu, Xiajie Wen, Ting Zhang, Jianwen Wang, Linbo Gao, Jing Zhang, Deyao Li, Huiling Zheng and Ting Zhang and has published in prestigious journals such as Gastroenterology, RSC Advances and Signal Transduction and Targeted Therapy.

In The Last Decade

Guiwen Guan

27 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guiwen Guan China 12 160 146 138 123 61 28 453
Zhen-Wei Lang China 10 145 0.9× 140 1.0× 182 1.3× 77 0.6× 51 0.8× 15 432
Bozong Tang China 11 107 0.7× 133 0.9× 77 0.6× 83 0.7× 34 0.6× 11 399
Jinsong Mu China 11 110 0.7× 62 0.4× 136 1.0× 59 0.5× 31 0.5× 20 307
Zhenzhen Zhang China 13 387 2.4× 225 1.5× 87 0.6× 301 2.4× 18 0.3× 45 761
Wenting Tan China 15 265 1.7× 99 0.7× 82 0.6× 232 1.9× 11 0.2× 41 555
Guiji Zhang China 8 67 0.4× 172 1.2× 141 1.0× 24 0.2× 27 0.4× 10 422
Xuwen Xu China 9 94 0.6× 274 1.9× 74 0.5× 40 0.3× 29 0.5× 29 485
Yandan Ren China 12 187 1.2× 285 2.0× 109 0.8× 89 0.7× 7 0.1× 18 518
Mahshid Panahi Iran 12 96 0.6× 142 1.0× 54 0.4× 27 0.2× 14 0.2× 48 413
Tai-Jay Chang Taiwan 10 62 0.4× 87 0.6× 42 0.3× 63 0.5× 22 0.4× 18 388

Countries citing papers authored by Guiwen Guan

Since Specialization
Citations

This map shows the geographic impact of Guiwen Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiwen Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiwen Guan more than expected).

Fields of papers citing papers by Guiwen Guan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiwen Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiwen Guan. The network helps show where Guiwen Guan may publish in the future.

Co-authorship network of co-authors of Guiwen Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Guiwen Guan. A scholar is included among the top collaborators of Guiwen Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guiwen Guan. Guiwen Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Bei, Guiwen Guan, Kaitao Zhao, et al.. (2025). Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B. Emerging Microbes & Infections. 14(1). 2475847–2475847. 2 indexed citations
2.
Zhao, Zhou, Xinyu Du, Yukun Li, et al.. (2025). Novel Function of NUP153 in HNF4α Transcriptional Upregulation Contributes to Promoting HBV Replication. Journal of Medical Virology. 97(3). e70256–e70256. 1 indexed citations
3.
Cheng, Zhenshun, et al.. (2025). Angiopoietins: multifaceted mediators in the pathogenesis of joint-related disorders. Histochemistry and Cell Biology. 163(1). 68–68. 1 indexed citations
4.
Gu, Zhiqiang, Mingwei Li, Na Gao, et al.. (2024). Hepatitis B virus enhancer 1 activates preS1 and preS2 promoters of integrated HBV DNA impairing HBsAg secretion. JHEP Reports. 6(9). 101144–101144. 6 indexed citations
5.
Guan, Guiwen, Zhiqiang Gu, Jing Yang, et al.. (2024). Multi‐omics panoramic analysis of HBV integration, transcriptional regulation, and epigenetic modifications in PLC/PRF/5 cell line. Journal of Medical Virology. 96(4). e29614–e29614. 4 indexed citations
6.
Wen, Xiajie, Xiaoning Wu, Yameng Sun, et al.. (2024). Long‐term antiviral therapy is associated with changes in the profile of transcriptionally active HBV integration in the livers of patients with CHB. Journal of Medical Virology. 96(6). e29606–e29606. 3 indexed citations
7.
Zhao, Chen, Jing Yang, Yang Song, et al.. (2024). HCC Model Induced by P53 and Pten Knockout in HBV‐Transgenic Mice Mirrors Human HCC at the Transcriptome Level. Journal of Medical Virology. 96(12). e70120–e70120.
8.
Liu, Tianxu, Xinyue Yang, Tianyu Tang, et al.. (2024). An Immunocompetent Mongolian Gerbil Model for Hepatitis E Virus Genotype 1 Infection. Gastroenterology. 167(4). 750–763.e10. 20 indexed citations
9.
Gao, Na, Guiwen Guan, Ganlin Xu, et al.. (2023). Integrated HBV DNA and cccDNA maintain transcriptional activity in intrahepatic HBsAg‐positive patients with functional cure following PEG‐IFN‐based therapy. Alimentary Pharmacology & Therapeutics. 58(10). 1086–1098. 15 indexed citations
10.
Zhang, Ting, Huiling Zheng, Guiwen Guan, et al.. (2023). RNA binding protein TIAR modulates HBV replication by tipping the balance of pgRNA translation. Signal Transduction and Targeted Therapy. 8(1). 346–346. 7 indexed citations
11.
Zou, Jun, Guiwen Guan, Xiaoyu Feng, et al.. (2023). The A1762T/G1764A mutations enhance HBV replication by alternating viral transcriptome. Journal of Medical Virology. 95(10). e29129–e29129. 6 indexed citations
12.
Zhang, Jing, Ting Zhang, Guiwen Guan, et al.. (2023). AUF1 promotes hepatocellular carcinoma progression and chemo-resistance by post-transcriptionally upregulating alpha-fetoprotein expression. Pathology - Research and Practice. 245. 154441–154441. 5 indexed citations
13.
Cheng, Jin, Congle Shen, Guiwen Guan, et al.. (2021). NFATc3 inhibits hepatocarcinogenesis and HBV replication via positively regulating RIG-I-mediated interferon transcription. OncoImmunology. 10(1). 1869388–1869388. 15 indexed citations
14.
Chen, Chia-Chen, Guiwen Guan, Xuewei Qi, et al.. (2021). Pacbio Sequencing of PLC/PRF/5 Cell Line and Clearance of HBV Integration Through CRISPR/Cas-9 System. Frontiers in Molecular Biosciences. 8. 676957–676957. 9 indexed citations
15.
Shu, Shi, Mingchen Liu, Hui Liu, et al.. (2020). Sex-determining region Y box 4 (SOX4) suppresses Hepatitis B virus replication by inhibiting hepatocyte nuclear factor 4α expression. Antiviral Research. 176. 104745–104745. 5 indexed citations
16.
Liu, Yongzhen, Jing Zhang, Guiwen Guan, et al.. (2019). Compensatory upregulation of aldo-keto reductase 1B10 to protect hepatocytes against oxidative stress during hepatocarcinogenesis.. PubMed. 9(12). 2730–2748. 19 indexed citations
17.
18.
Zhang, Ting, Guiwen Guan, Tingting Chen, et al.. (2018). Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology. 14(5). e352–e358. 21 indexed citations
19.
Wang, Jie, Ran Chen, Ruiyang Zhang, et al.. (2017). The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication. Theranostics. 7(12). 3090–3105. 45 indexed citations
20.
Yao, Mingjie, Patrick S.C. Leung, Yanmei Li, et al.. (2017). The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review. Clinical Reviews in Allergy & Immunology. 54(2). 282–294. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026